[Editors' note:Follow progress with legislation impacting the device and diagnostics industry with Medtech Insight's US Congress Tracker.]
President Trump quietly signed the FDA Reauthorization Act Aug. 18, authorizing about $1bn in device user-fee collections over the next five years and a range of reforms and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?